Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults

NCT04818281 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: SARS-CoV-2 VLP Vaccine
BIOLOGICAL: Placebo

Sponsor

Ihsan GURSEL, PhD, Prof.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]